Task: Answer the multiple-choice question.
Query: Which drug exhibits a -19.017% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) O=C(O)c1ccc(NS(=O)(=O)/C=C/c2ccccc2)cc1
(b) CC(O)[C@H]1CNC(=O)C(=O)N1CCc1cccc2ccccc12
(c) CCCOc1ccc(S(=O)(=O)NCCCN2CCOCC2)c2ccccc12
Answer: c. CCCOc1ccc(S(=O)(=O)NCCCN2CCOCC2)c2ccccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCOc1ccc(S(=O)(=O)NCCCN2CCOCC2)c2ccccc12
CCCOc1ccc(S(=O)(=O)NCCCN2CCOCC2)c2ccccc12
N-(3-morpholin-4-ylpropyl)-4-propoxynaphthalene-1-sulfonamide